CUROSURF SUSP VIAL

Introducing CUROSURF SUSP VIAL, a revolutionary surfactant therapy designed to enhance lung function in neonates suffering from Respiratory Distress Syndrome (RDS). This innovative product is essential for healthcare professionals seeking effective treatment options for premature infants with compromised lung development.

CUROSURF is formulated with a natural porcine-derived surfactant that mimics the body’s own surfactant, promoting alveolar stability and improving oxygenation. Each vial contains a precise dosage, ensuring optimal delivery and efficacy. The product is packaged in a sterile environment, maintaining the highest standards of safety and quality.

Key features of CUROSURF SUSP VIAL include:

• Effective Treatment for RDS: Specifically designed to address the needs of premature infants, helping to reduce the incidence of complications associated with RDS.
• Natural Surfactant Composition: Made from porcine lung extract, providing a biocompatible solution that works harmoniously with the infant's physiology.
• Easy Administration: The vial is designed for straightforward use, allowing healthcare providers to deliver the surfactant efficiently and effectively.
• Proven Clinical Efficacy: Backed by extensive research and clinical trials, CUROSURF has demonstrated significant improvements in lung function and survival rates in affected neonates.

With an EAN of 09348450000586 and a manufacturer code of EH11002, CUROSURF SUSP VIAL is a trusted choice for neonatal care. Ensure the best possible outcomes for your patients with this essential surfactant therapy.